Approval of Capital expenditure
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 4.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Directors of Jaysynth Orgochem Ltd approved a capital expenditure of ₹7.75 Crores on November 12, 2025. The investment will fund capacity expansion for Reactive, Disperse & Pigment Inks at the company's Patalganga manufacturing unit, debottlenecking of the Pigment dispersion plant, and shifting of Dyes plant operations from Taloja to Patalganga. Existing capacity stands at 1,100 MT per year running at 85% utilisation, with a proposed addition of 1,800–2,000 MT per year to be rolled out in phases starting Q4 FY2025-2026. The entire investment will be funded through internal accruals, with no external borrowing involved.
This expansion is a growth-oriented move to capture rising demand in digital printing inks and consolidate operations at a single facility. For shareholders, it signals management's confidence in future demand and is funded internally without adding debt, though short-term returns on the capex will depend on how quickly the new capacity is utilised.